ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas
Authors:
- Amanda K. ArringtonAAAmanda K. Arrington
- Peter S. DahlbergPDPeter S. Dahlberg
- Julia DavydovaJDJulia Davydova
- Selwyn M. VickersSVSelwyn M. Vickers
- Masato YamamotoMYMasato Yamamoto
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- ErbB-2 Induces the Cyclin D1 Gene in Prostate Epithelial Cells In vitro and In vivoCancer Research, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Genetic Alterations in Esophageal CancerSurgery Today, 2005
- Molecular biology of upper gastrointestinal malignanciesSeminars in Oncology, 2004
- Tyrosine kinase inhibitors: Why does the current process of clinical development not apply to them?Cancer Cell, 2004
- Molecular Biology of Esophageal CancerOncology Research and Treatment, 2004
- Gene expression profiles in esophageal adenocarcinomaThe Annals of Thoracic Surgery, 2004
- The ErbB receptors and their role in cancer progressionExperimental Cell Research, 2003
- Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinomaBritish Journal of Surgery, 2002
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989